Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 3;20(9):1726-1735.
doi: 10.2174/1570159X20666211223125448.

Homocysteinylation and Sulfhydration in Diseases

Affiliations
Review

Homocysteinylation and Sulfhydration in Diseases

Si-Min Chen et al. Curr Neuropharmacol. .

Abstract

Homocysteine (Hcy) is an important intermediate in methionine metabolism and generation of one-carbon units, and its dysfunction is associated with many pathological states. Although Hcy is a non-protein amino acid, many studies have demonstrated protein-related homocysteine metabolism and possible mechanisms underlying homocysteinylation. Homocysteinylated proteins lose their original biological function and have a negative effect on the various disease phenotypes. Hydrogen sulfide (H2S) has been recognized as an important gaseous signaling molecule with mounting physiological properties. H2S modifies small molecules and proteins via sulfhydration, which is supposed to be essential in the regulation of biological functions and signal transduction in human health and disorders. This review briefly introduces Hcy and H2S, further discusses pathophysiological consequences of homocysteine modification and sulfhydryl modification, and ultimately makes a prediction that H2S might exert a protective effect on the toxicity of homocysteinylation of target protein via sulfhydration. The highlighted information here yields new insights into the role of protein modification by Hcy and H2S in diseases.

Keywords: Homocysteine; diseases; homocysteinylation; hydrogen sulfide; protein modification; sulfhydration.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Pathways of Hcy Metabolism. ① the generative pathway of homocysteine; ‚ the remethylation pathway; ƒ the transsulfuration pathway; „ the homocysteine-thiolactone pathway; … the reversible pathway of homocysteine generation. Abbreviations: Hcy, homocysteine; Met, methionine; AdoMet, adenosylmethionine; AdoHcy, adenosylhomocysteine; Cys, cysteine; HTL, homocysteine thiolactone; N-Hcy-protein, N-homocysteined protein; S-Hcy-protein, S-homocysteined protein; MS, Met synthase; MAT, Met S-adenosyltransferase; CBS, cystathionine β-synthase; CSE, cystathionine γ–lyase; MetRS, methionyl-tRNA synthetase; PON1, paraoxonase 1; SAHH, S-adenosylhomocysteine hydrolase; VB6, vitamin B6; VB12, vitamin B12.
Fig. (2)
Fig. (2)
Pathways of protein homocysteinylation. Abbreviations: Hcy, homocysteine; MetRS, methionyl-tRNA synthetase; HTL, homocysteine thiolactone.
Fig. (3)
Fig. (3)
Pathways of H2S production. Abbreviations: Hcy, homocysteine; Cys, cysteine; SQR, sulfide: quinone oxidoreductase; 3-MP, 3-mercaptopytuvate; CBS, cystathionine β-synthase; D-AAO, D-amino acid oxidase; 3-MST, 3-mercaptopyruvate sulfurtransferase; CAT, cysteine aminotransferase; CSE, cystathionine γ–lyase; VB6, vitamin B6.
Fig. (4)
Fig. (4)
Effects of H2S or sulfhydration on diseases. H2S exerts protective effects on vasorelaxation, myocardial injury, redox homeostasis, endothelial injury, and fibrin lysis.

References

    1. Jakubowski H. Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J. Biol. Chem. 2002;277(34):30425–30428. doi: 10.1074/jbc.C200267200. - DOI - PubMed
    1. Sikora M., Marczak Ł., Kubalska J., Graban A., Jakubowski H. Identification of N-homocysteinylation sites in plasma proteins. Amino Acids. 2014;46(1):235–244. doi: 10.1007/s00726-013-1617-7. - DOI - PubMed
    1. Jacovina A.T., Deora A.B., Ling Q., Broekman M.J., Almeida D., Greenberg C.B., Marcus A.J., Smith J.D., Hajjar K.A. Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J. Clin. Invest. 2009;119(11):3384–3394. doi: 10.1172/JCI39591. - DOI - PMC - PubMed
    1. Hortin G.L., Seam N., Hoehn G.T. Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins. Clin. Chem. 2006;52(12):2258–2264. doi: 10.1373/clinchem.2006.074302. - DOI - PubMed
    1. Jakubowski H. Homocysteine in protein structure/function and human disease. Springer-Verlag; 2013. - DOI - PubMed